Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis.

Childhood abuse Childhood maltreatment Meta-analysis Opioid dependence Opioid use disorders Prevalence

Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 02 2021
Historique:
received: 22 09 2020
revised: 23 11 2020
accepted: 24 11 2020
pubmed: 6 1 2021
medline: 12 5 2021
entrez: 5 1 2021
Statut: ppublish

Résumé

Experience of childhood maltreatment (CM) is a risk factor for opioid use disorder (OUD). CM is also associated with comorbid mental disorders and poor treatment outcomes among people with OUD. To our knowledge, this is the first systematic review and meta-analysis to estimate the prevalence of CM among people with OUD. We searched MEDLINE, EMBASE, and PsycINFO to identify observational studies that evaluated CM among people with OUD from January 1990 to June 2020. Prevalence of each CM type, sample characteristics, and methodological factors were extracted from each eligible study. Random-effects meta-analyses were used to pool prevalence estimates. Stratified meta-analyses were used to assess heterogeneity. Of the 6,438 publications identified, 113 studies reported quantitative CM data among people with OUD and 62 studies (k = 62; N = 21,871) were included in primary analyses. Among people with OUD, the estimated prevalence of sexual abuse was 41% (95% CI 36-47%; k = 38) among women and 16% (95% CI 12-20%; k = 25) among men. Among all people with OUD, prevalence estimates were 38% (95% CI 33-44%; k = 48) for physical abuse, 43% (95% CI 38-49%; k = 31) for emotional abuse, 38% (95% CI 30-46%; k = 17) for physical neglect, and 42% (95% CI 32-51%; k = 17) for emotional neglect. Sex, history of injecting drug use, recruitment methods, and method of assessing CM were associated with substantial heterogeneity. People with OUD frequently report the experience of CM, supporting the need for trauma-informed interventions among this population. Future research should consider the impact of CM on OUD presentations and when assessment is appropriate, use of validated instruments.

Sections du résumé

BACKGROUND
Experience of childhood maltreatment (CM) is a risk factor for opioid use disorder (OUD). CM is also associated with comorbid mental disorders and poor treatment outcomes among people with OUD. To our knowledge, this is the first systematic review and meta-analysis to estimate the prevalence of CM among people with OUD.
METHODS
We searched MEDLINE, EMBASE, and PsycINFO to identify observational studies that evaluated CM among people with OUD from January 1990 to June 2020. Prevalence of each CM type, sample characteristics, and methodological factors were extracted from each eligible study. Random-effects meta-analyses were used to pool prevalence estimates. Stratified meta-analyses were used to assess heterogeneity.
RESULTS
Of the 6,438 publications identified, 113 studies reported quantitative CM data among people with OUD and 62 studies (k = 62; N = 21,871) were included in primary analyses. Among people with OUD, the estimated prevalence of sexual abuse was 41% (95% CI 36-47%; k = 38) among women and 16% (95% CI 12-20%; k = 25) among men. Among all people with OUD, prevalence estimates were 38% (95% CI 33-44%; k = 48) for physical abuse, 43% (95% CI 38-49%; k = 31) for emotional abuse, 38% (95% CI 30-46%; k = 17) for physical neglect, and 42% (95% CI 32-51%; k = 17) for emotional neglect. Sex, history of injecting drug use, recruitment methods, and method of assessing CM were associated with substantial heterogeneity.
CONCLUSIONS
People with OUD frequently report the experience of CM, supporting the need for trauma-informed interventions among this population. Future research should consider the impact of CM on OUD presentations and when assessment is appropriate, use of validated instruments.

Identifiants

pubmed: 33401031
pii: S0376-8716(20)30624-4
doi: 10.1016/j.drugalcdep.2020.108459
pmc: PMC7855829
mid: NIHMS1658611
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108459

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA044170
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA021525
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA038886
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Am J Drug Alcohol Abuse. 2010 Jan;36(1):7-12
pubmed: 20141390
Issues Ment Health Nurs. 2019 Aug;40(8):690-696
pubmed: 31100036
J Anxiety Disord. 2010 Jan;24(1):49-54
pubmed: 19775865
J Adolesc Health. 2009 Sep;45(3):300-2
pubmed: 19699428
Am J Drug Alcohol Abuse. 1999 Nov;25(4):593-606
pubmed: 10548437
Subst Use Misuse. 2016;51(3):277-94
pubmed: 26886405
Compr Psychiatry. 2010 Jul-Aug;51(4):419-25
pubmed: 20579517
Contemp Clin Trials. 2017 Sep;60:105-112
pubmed: 28689852
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Drug Alcohol Depend. 2018 Jul 1;188:161-168
pubmed: 29778009
Subst Use Misuse. 2016 May 11;51(6):763-76
pubmed: 27096889
PLoS One. 2019 Dec 27;14(12):e0225854
pubmed: 31881035
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
J Psychoactive Drugs. 2016 Sep-Oct;48(4):279-87
pubmed: 27430532
JAMA Psychiatry. 2015 Nov;72(11):1135-42
pubmed: 26465073
Cochrane Database Syst Rev. 2011 Oct 05;(10):CD004147
pubmed: 21975742
Am J Drug Alcohol Abuse. 2016;42(1):98-110
pubmed: 26636885
Drug Alcohol Depend. 2018 Oct 1;191:145-151
pubmed: 30107320
Neurobiol Stress. 2019 Jan 07;10:100144
pubmed: 30937350
Addict Behav. 2014 Feb;39(2):473-9
pubmed: 24238782
Addict Behav. 2015 Apr;43:83-8
pubmed: 25588793
Soc Sci Med. 2003 Aug;57(3):561-9
pubmed: 12791497
Addict Behav. 2016 Sep;60:165-70
pubmed: 27155243
Drug Alcohol Depend. 2009 Jul 1;103(1-2):16-24
pubmed: 19414225
Addiction. 2010 Jun;105(6):1062-70
pubmed: 20331567
J Subst Abuse Treat. 2012 Oct;43(3):366-76
pubmed: 22444420
Psychiatry Res. 2013 Nov 30;210(1):8-15
pubmed: 23790604
Am J Drug Alcohol Abuse. 1997 Nov;23(4):581-95
pubmed: 9366975
J Psychoactive Drugs. 2002 Jan-Mar;34(1):97-103
pubmed: 12003119
Child Maltreat. 2007 May;12(2):137-49
pubmed: 17446567
Drug Alcohol Depend. 2017 Aug 1;177:29-38
pubmed: 28551591
Addict Behav. 2009 Sep;34(9):723-9
pubmed: 19447563
Am J Addict. 2013 Mar-Apr;22(2):127-31
pubmed: 23414497
Child Maltreat. 2006 Feb;11(1):49-62
pubmed: 16382091
Clin J Pain. 2016 Apr;32(4):292-301
pubmed: 26295378
Psychol Med. 2006 Oct;36(10):1473-83
pubmed: 16854248
J Affect Disord. 2019 Sep 1;256:448-457
pubmed: 31252238
Inj Epidemiol. 2017 Dec;4(1):24
pubmed: 28762157
Addict Behav. 2017 Jun;69:98-103
pubmed: 28219827
Addiction. 2014 Apr;109(4):610-6
pubmed: 24279327
J Ethn Subst Abuse. 2014;13(3):258-72
pubmed: 25176119
Child Abuse Negl. 2019 Mar;89:165-177
pubmed: 30685624
Addict Behav. 2020 Mar;102:106149
pubmed: 31855783
J Psychoactive Drugs. 1995 Oct-Dec;27(4):421-33
pubmed: 8788697
JAMA Intern Med. 2019 Apr 1;179(4):476-478
pubmed: 30742214
Alcohol Res Health. 2006;29(1):55-62
pubmed: 16767855
Am J Addict. 2007 Nov-Dec;16(6):431-8
pubmed: 18058406
J Addict Med. 2015 Nov-Dec;9(6):433-9
pubmed: 26335004
J Consult Clin Psychol. 2019 Oct;87(10):941-951
pubmed: 31556670
Drug Alcohol Depend. 2017 Oct 1;179:325-329
pubmed: 28841495
J Psychoactive Drugs. 2019 Nov-Dec;51(5):441-452
pubmed: 31411548
JAMA Psychiatry. 2019 Jun 1;76(6):584-593
pubmed: 30892562
Curr Opin Psychol. 2019 Dec;30:17-23
pubmed: 30711906
BMC Res Notes. 2018 Jan 16;11(1):35
pubmed: 29338770
Drug Alcohol Rev. 2009 Nov;28(6):600-7
pubmed: 19930012
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD002209
pubmed: 19588333
Soc Psychiatry Psychiatr Epidemiol. 2013 Mar;48(3):345-55
pubmed: 22797133
Drug Alcohol Depend. 2011 Dec 1;119(1-2):106-12
pubmed: 21715108
Clin Psychol Rev. 2002 Mar;22(2):271-95
pubmed: 11806022
Child Abuse Negl. 2009 Jun;33(6):343-52
pubmed: 19477004
J Interpers Violence. 2006 Jan;21(1):121-38
pubmed: 16399927
Drug Alcohol Depend. 2011 Dec 1;119(1-2):93-8
pubmed: 21715105
Can J Psychiatry. 2012 Nov;57(11):677-86
pubmed: 23149283
Arch Public Health. 2014 Nov 10;72(1):39
pubmed: 25810908
JAMA Psychiatry. 2020 May 1;77(5):493-502
pubmed: 31876906
Drug Alcohol Depend. 2016 May 1;162:51-5
pubmed: 26993373
Am J Psychiatry. 2017 Aug 1;174(8):738-747
pubmed: 27978771
J Subst Abuse Treat. 2005 Oct;29(3):231-5
pubmed: 16183472
Am J Orthopsychiatry. 2003 Oct;73(4):392-404
pubmed: 14609401
Am J Orthopsychiatry. 2011 Apr;81(2):211-7
pubmed: 21486263
J Subst Abuse Treat. 2000 Jul;19(1):31-7
pubmed: 10867298
Am J Drug Alcohol Abuse. 2009;35(5):305-10
pubmed: 19637103
J Stud Alcohol. 2006 Mar;67(2):228-35
pubmed: 16562404
J Paediatr Child Health. 2004 Aug;40(8):455-60
pubmed: 15265187
Soc Sci Med. 2002 Sep;55(5):803-21
pubmed: 12190272
Am J Addict. 2017 Sep;26(6):551-563
pubmed: 28675762
Drug Alcohol Depend. 2013 Dec 1;133(2):420-6
pubmed: 23906996
Womens Health Issues. 2008 Jan-Feb;18(1):35-43
pubmed: 18215763
Subst Use Misuse. 2014 Aug;49(10):1311-6
pubmed: 24708431
PLoS One. 2020 May 15;15(5):e0233185
pubmed: 32413081
Drug Alcohol Depend. 2017 Sep 1;178:318-339
pubmed: 28688295
BMJ. 2017 Apr 26;357:j1550
pubmed: 28446428
Drug Alcohol Depend. 2019 May 1;198:28-33
pubmed: 30877954
J Soc Work Pract Addict. 2013;13(3):
pubmed: 24319347
Addiction. 2007 Dec;102(12):1933-41
pubmed: 17784898
J Clin Psychiatry. 2019 Dec 3;81(1):
pubmed: 31846246
Psychiatry Res. 2019 Jan;271:381-388
pubmed: 30529875
Drug Alcohol Depend. 1996 May;41(1):1-7
pubmed: 8793304
Soc Work Health Care. 2010;49(9):799-813
pubmed: 20938876
J Prim Prev. 2020 Apr;41(2):139-152
pubmed: 31989435
Int J Psychol. 2013;48(2):81-94
pubmed: 23597008
Am J Addict. 2016 Oct;25(7):542-8
pubmed: 27629823
Suicide Life Threat Behav. 2010 Feb;40(1):50-62
pubmed: 20170261
Addiction. 2001 Feb;96(2):227-40
pubmed: 11182867
Drug Alcohol Depend. 2020 Sep 1;214:108188
pubmed: 32717502
Addict Behav. 2011 Jan-Feb;36(1-2):27-36
pubmed: 20833480
J Addict Dis. 2009;28(1):64-7
pubmed: 19197597
Child Maltreat. 2011 May;16(2):79-101
pubmed: 21511741
Addict Behav. 2000 Sep-Oct;25(5):797-803
pubmed: 11023022
Child Abuse Negl. 2002 Dec;26(12):1275-89
pubmed: 12464301
Drug Alcohol Depend. 2019 Feb 1;195:132-139
pubmed: 30634108
J Ment Health. 2019 Jul 26;:1-9
pubmed: 31347421
Addict Behav. 2019 Sep;96:171-174
pubmed: 31102882
Addict Health. 2011 Summer-Autumn;3(3-4):92-8
pubmed: 24494122
Psychol Addict Behav. 2001 Sep;15(3):177-84
pubmed: 11563794
Addiction. 2013 Apr;108(4):659-67
pubmed: 23075121
Nat Med. 2020 May;26(5):651-652
pubmed: 32367061
Eur Neuropsychopharmacol. 2012 Dec;22(12):883-91
pubmed: 22564825
Drug Alcohol Rev. 2016 Nov;35(6):686-692
pubmed: 26711174
Addiction. 2002 Nov;97(11):1383-94
pubmed: 12410779
Lancet. 2019 Oct 26;394(10208):1560-1579
pubmed: 31657732
PLoS One. 2010 Dec 29;5(12):e15882
pubmed: 21209959
J Community Health. 2010 Aug;35(4):423-32
pubmed: 20358265

Auteurs

Thomas Santo (T)

National Drug and Alcohol Research Centre, UNSW Sydney, 22-32 King Street, Randwick, NSW, 2031, Australia. Electronic address: t.santo@unsw.edu.au.

Gabrielle Campbell (G)

National Drug and Alcohol Research Centre, UNSW Sydney, 22-32 King Street, Randwick, NSW, 2031, Australia; School of Health and Sports Sciences, University of the Sunshine Coast, Sunshine Coast, QLD, 4556, Australia.

Natasa Gisev (N)

National Drug and Alcohol Research Centre, UNSW Sydney, 22-32 King Street, Randwick, NSW, 2031, Australia.

Lucy Thi Tran (LT)

National Drug and Alcohol Research Centre, UNSW Sydney, 22-32 King Street, Randwick, NSW, 2031, Australia.

Samantha Colledge (S)

National Drug and Alcohol Research Centre, UNSW Sydney, 22-32 King Street, Randwick, NSW, 2031, Australia.

Gian Luca Di Tanna (GL)

The George Institute for Global Health, UNSW Sydney, 1 King Street, Newtown, NSW, 2042, Australia; Faculty of Medicine, UNSW Sydney, Wallace Wurth Building, 18 High Street, Kensington, NSW, 2052, Australia.

Louisa Degenhardt (L)

National Drug and Alcohol Research Centre, UNSW Sydney, 22-32 King Street, Randwick, NSW, 2031, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH